In the third quarter of 2024, Thermo Fisher Scientific reported a revenue miss of approximately $50 million. Despite this shortfall, the company's earnings call was viewed positively by analysts ...

Credit: Jonathan Weiss/Shutterstock. Thermo Fisher Scientific, a biotechnology research company, has enhanced sustainability with the launch of a new packaging for 125,000 of its Invitrogen antibodies ...

Evercore ISI increased their price target on shares of Thermo Fisher Scientific from $605.00 to $630.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st.

Beaumont Financial Advisors LLC grew its position in Thermo Fisher Scientific by 0.8% in the 1st quarter. Beaumont Financial Advisors LLC now owns 2,199 shares of the medical research company’s ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Not anymore. While the uplift from covid-19 tests and vaccines has been significant, the swiftness and extent of the company's response has cemented Thermo Fisher's integral role within the segment.